EUVIMEDEUVIMED entdecken
Fallbericht

Episcleritis and periorbital edema secondary to VEXAS syndrome

P Fanlo, M López de San Román, A Fonollosa, J Ilarramendi, H Heras, P Grayson

Archivos de la Sociedad Española de Oftalmología (English Edition) · 2023

DOI: 10.1016/j.oftale.2023.07.004 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Archivos de la Sociedad Española de Oftalmología (English Edition), 2023. Verfasst von P Fanlo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Interna, Hospital Universitario de Navarra, Pamplona, Spain. Electronic address: patriciafanlo@yahoo.es. Hauptthemen laut MEDLINE: Scleritis, Eye Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly described autoinflammatory entity caused by a UBA-1 gene mutation. Among the most frequent symptoms it produces fever, cytopenias, polychondritis, pulmonary infiltrates and up to 40% ocular involvement such as periorbital edema, uveitis, episcleritis, scleritis and retinal vasculitis. Patients respond to high doses of corticosteroids, however, many end up being refractory to them and to the classic immunosuppressants. We described the case of a 77-year-old male patient with ocular involvement in the form of episcleritis and periorbital edema who was later diagnosed with VEXAS Syndrome. The patient, after failing treatment with immunosuppressants, is currently receiving treatment with oral steroids and tocilizumab. Ophthalmologist must be aware of the ophthalmological affectation of autoinflammatory diseases and especially of this new entity described as the VEXAS Syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScleritisEye DiseasesSkin Diseases, GeneticMaleHumansEyeAgedMyelodysplastic SyndromesEdemaCellulitis

Stichwörter der Autor:innen

Edema periorbitarioEpiescleritisEpiscleritisPeriorbital edemaSíndrome VEXASTocilizumabVEXAS syndrome

Autor:innen und Institutionen

  • Servicio de Medicina Interna, Hospital Universitario de Navarra, Pamplona, Spain. Electronic address: patriciafanlo@yahoo.es.
  • Servicio de Medicina Interna, Hospital Universitario de Navarra, Pamplona, Spain.
  • Department of Ophthalmology, Instituto de Investigación Sanitaria de Vizcaya Biocruces, Hospital Universitario de Cruces, Universidad del País Vasco, Instituto Oftalmológico Bilbao, Bilbao, Spain.
  • Servicio de Hematología, Hospital Universitario de Navarra, Pamplona, Spain.
  • Servicio de Oftalmología, Hospital Universitario de Navarra, Pamplona, Spain.
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, Spain.

Zitieren

APA

Fanlo, P., Román, M. L. S., Fonollosa, A., Ilarramendi, J., Heras, H., & Grayson, P. (2023). Episcleritis and periorbital edema secondary to VEXAS syndrome. Archivos de la Sociedad Española de Oftalmología (English Edition). https://doi.org/10.1016/j.oftale.2023.07.004

Vancouver

Fanlo P, Román MLS, Fonollosa A, Ilarramendi J, Heras H, Grayson P. Episcleritis and periorbital edema secondary to VEXAS syndrome. Archivos de la Sociedad Española de Oftalmología (English Edition). 2023. doi:10.1016/j.oftale.2023.07.004

BibTeX
@article{Fanlo2023,
  author = {Fanlo, P and Román, M López de San and Fonollosa, A and Ilarramendi, J and Heras, H and Grayson, P},
  title = {Episcleritis and periorbital edema secondary to VEXAS syndrome},
  journal = {Archivos de la Sociedad Española de Oftalmología (English Edition)},
  year = {2023},
  doi = {10.1016/j.oftale.2023.07.004}
}
Kostenlos starten →